Get the StoQuant digest — free

Free StoQuant digest by email. No account needed. See today's research picks.

Subscribe free

CNTB vs MIST — Stock Comparison

Compare CNTB and MIST side-by-side on StoQuant: CNTB Q-Score 50 vs MIST 21; analyst signal 77 vs 77. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.

Side-by-side snapshot

• CNTB — Connect Biopharma Holdings Limited · Health Care · market cap $48M · Q-Score verdict Unrated (50.0) · analyst signal 77/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: competitive moat 93/100, analyst consensus 84/100 · weakest signals: technicals 1/100. Full CNTB research.
• MIST — Milestone Pharmaceuticals Inc. · Health Care · market cap $81M · Q-Score verdict Strong Sell (21.0, grade F) · analyst signal 77/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 81/100, valuation 74/100 · weakest signals: technicals 3/100, competitive moat 1/100. Full MIST research.

What you can compare

• Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
• Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
• Insider activity: Cluster scores and recent Form 4 buying.
• Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
• Strategic edges: Competitive moat and durable advantage analysis.
• Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
• Macro context: Market regime and sector rotation alignment.

Deep dive: CNTB research · MIST research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →